TickerFacts.

Volitionrx Ltd (VNRX): Operating Income

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the years ended 2016-12-31, 2017-12-31 (for example after a spin-off or a discontinued operation), while the year before each was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

-$21.74M
Year ended 2025-12-31
-$19.45M
Trailing 12 months to 2026-06-30
2011-12-31: -$2.61M2012-12-31: -$4.08M2013-12-31: -$4.58M2014-12-31: -$5.95M2015-12-31: -$10.01M2016-12-31: -$12.43M2017-12-31: -$14.70M2018-12-31: -$17.90M2019-12-31: -$16.04M2020-12-31: -$21.25M2021-12-31: -$28.33M2022-12-31: -$31.78M2023-12-31: -$35.99M2024-12-31: -$27.02M2025-12-31: -$21.74M-$21.74M
2011-12-31 Operating Income (USD) 2025-12-31
Period endedOperating IncomeChange YoYSource filing
2025-12-31-$21.74Mn/m2026-03-31, From 2025-01-01
2024-12-31-$27.02Mn/m2026-03-31, From 2024-01-01
2023-12-31-$35.99Mn/m2025-03-31, From 2023-01-01
2022-12-31-$31.78Mn/m2024-03-25, From 2022-01-01
2021-12-31-$28.33Mn/m2023-03-15, From 2021-01-01
2020-12-31-$21.25Mn/m2022-03-30, From 2020-01-01
2019-12-31-$16.04Mn/m2021-03-22, From 2019-01-01
2018-12-31-$17.90Mn/m2020-02-20, From 2018-01-01
2017-12-31-$14.70Mn/c2019-03-13, From 2017-01-01
2016-12-31-$12.43Mn/c2018-03-01, From 2016-01-01
2015-12-31-$10.01Mn/m2017-03-10, From 2015-01-01
2014-12-31-$5.95Mn/m2016-03-11, From 2014-01-01
2013-12-31-$4.58Mn/m2015-03-18, From 2013-01-01
2012-12-31-$4.08Mn/m2014-03-28, From 2012-01-01
2011-12-31-$2.61Mn/a2013-04-01, From 2011-01-01

Operating Income at similar companies

Companies with the same SEC industry code (In Vitro & In Vivo Diagnostic Substances), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating IncomeChange YoY
Volitionrx Ltd (VNRX)2025-12-31-$21.74Mn/m
Celldex Therapeutics, Inc. (CLDX)2025-12-31-$287.37Mn/m
Insight Molecular Diagnostics Inc. (IMDX)2025-12-31-$51.12Mn/m
Biomerica Inc (BMRA)2026-05-31-$5.32Mn/m
Anbio Biotechnology (NNNN)2025-12-31$5.77M+189.1%
Aspira Women's Health Inc. (AWHL)2025-12-31-$7.91Mn/m
Immucell Corp (ICCC)2025-12-31$1.65Mn/m
Alpha Teknova, Inc. (TKNO)2025-12-31-$16.98Mn/m
Intellia Therapeutics, Inc. (NTLA)2025-12-31-$440.99Mn/m

Compare VNRX, CLDX, IMDX, BMRA side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗